NSW startup Cauldron adds $19 million to its funding pot
Regional NSW startup Cauldron has also been named among the most innovative companies in the Asia-Pacific.
New South Wales biomanufacturing startup Cauldron has secured $19 million (US$13.25 million) in new funding in a Series A2 round led by leading deep tech venture firm Main Sequence Ventures.
Horizon Ventures, SOSV and NGS Super also backed the Orange-based startup, which has now raised a total of $37 million (US$26 million) in funding to date.
At the same time, the company is continuing to receive international attention, having this week been named on Fast Company‘s latest list of the Most Innovative Companies in the Asia-Pacific.
Sign up to continue
You've reached your article limit. Create a free account, or log in to continue.
Get our free newsletters in your inbox and extended article access by submitting your email.
Comments